March 2, 2022
Research News Roundup — January, February 2022
By Advancing the Science contributor
At Mayo Clinic, researchers work across the spectrum of health care and disease, from basic discovery science to transformations in patient care. They translate early findings into therapeutic or preventive interventions via clinical research and innovative pilot projects. Mayo Clinic researchers publish thousands of articles in peer-reviewed journals each year. A fraction of those findings […]
Tags: A. Noelle Larson, Andrew Bentall, animal model, anticoagulant, biomedical engineering, bone regeneration, cardiovascular disease, chemotherapy, cirrhosis, COVID-19, gastrointestinal cancer, health disparities
February 16, 2021
Mayo Clinic Research in the news — 2/15/2021
By Advancing the Science contributor
Mayo Clinic research and faculty were highlighted in a range of articles over the last week. Headlines and links below to stories on research collaborations and expansions, as well as specific disease advancements, and all the latest COVID-19 news and information. Ionic liquid formulation can uniformly deliver chemotherapy to tumors while destroying cancerous tissue in […]
Tags: aging, Alzheimer's disease, antibodies, cancer, CAR-T cell therapy, COVID-19, diabetes, gastrointestinal cancer, heart failure, hereditary diseases, News of the Week, opioids
January 7, 2020
Research News Roundup–December 2019
December’s Research News Roundup highlights a number of advancements in understanding and treating different cancers, including blood, breast and gastrointestinal; in addition to other research news from Mayo Clinic. The Roundup also connects readers to related resources. Read on for more information from Mayo Clinic Research. Study finds less-aggressive chemotherapy after initial treatment for metastatic colorectal […]
Tags: breast cancer, cancer, cancer genomics, CAR-T cell therapy, cardiovascular medicine, chemotherapy, chronic lymphocytic leukemia, colorectal cancer, endometrial cancer, gastrointestinal cancer, hematology, Mayo Clinic Cancer Center
October 4, 2019
Chemo first for better outcomes in bile duct cancer, says new research
Oncology care teams frequently use chemotherapy along with surgery to treat cholangiocarcinoma, or bile duct cancer. However, until now, little evidence existed regarding if and when receiving chemotherapy was likely to have the best effect. Recently Mayo Clinic researchers found that patients who received chemotherapy before surgery to remove their bile duct cancer were more […]
Tags: Amit Mahipal, bile ducts, cancer, Center for the Science of Health Care Delivery, chemotherapy, cholangiocarcinoma, gastrointestinal cancer, hematology, Mayo Clinic Cancer Center, oncology, rare disease, Siddhartha Yadav
July 31, 2019
Identifying hereditary cancer risk: genetic testing can lead to better screening, earlier treatment
By Advancing the Science contributor
By Sharon Rosen Do you have family members who have been diagnosed with gastrointestinal, breast or ovarian cancer? According to a recent Mayo Clinic study, nearly 5% to 10% of these cancers can be hereditary. That’s why it is important to share your family medical history with your physician, who can determine if you and […]
Tags: breast cancer, cancer, Center for Individualized Medicine, gastrointestinal cancer, genetic testing, hereditary cancer, Mayo Clinic Cancer Center, Mayo Clinic Proceedings, Niloy "Jewel" Samadder, ovarian cancer
October 3, 2018
Mayo Clinic Awarded Nation’s First Hepatobiliary SPORE Grant
The National Cancer Institute (NCI) has awarded Mayo Clinic an $11.5 million grant to fund a Specialized Program of Research Excellence (SPORE) in hepatobiliary cancer through August 2023. Headed by principal investigators Mark A. McNiven, Ph.D., and Lewis R. Roberts, M.B., Ch.B., Ph.D., the goal of the Mayo Clinic Hepatobiliary SPORE is to make discoveries […]
Tags: cancer, Chen Wang, Edward Leof, gastrointestinal cancer, Gregory Gores, John Copland III, Lewis Roberts, liver cancer, Mark McNiven, Mark Truty, Mayo Clinic Cancer Center, Michael Torbenson